ECE 2007

The 9th European Congress of Endocrinology is being hosted by the Hungarian Society of Endocrinology and Metabolism and will be held at Papp Lászlό Budapest Sportaréna, H-1143 Budapest, Stefánia út 2. Hungary from 28 April until 2 May 2007. Attendees are expected from all over the world to learn from the latest advances in endocrine research and clinical care presented by the thought leaders in the field. The POC has actively worked to put together a programme of scientific excellence that will be attractive to all professionals interested in endocrinology and metabolism. On-line registration form is available via the link below or for further information, visit www.ece2007.com.

Register

E-Vote for Election to the ESE Executive Committee

Information regarding the e-vote and the candidate details will be available on the ESE website by the end of February 2007. Results of the voting will be announced at the Annual General Meeting, to be held at the ECE 2007, Budapest.

On Line Membership renewal now available

Your membership can now be renewed online. Before making payment you will need to obtain a password. Full instructions on how to obtain this will be detailed on the website, see the link below.

Online membership

Membership applications

All applications for Ordinary membership are formally approved by the ESE Executive Committee and by the full membership at the Annual General Meeting. The closing date for applications to be approved at the 2007 AGM has now passed. Any applications received from 7 February 2007 will be approved at the 2008 AGM. Further details regarding membership and the application form can be found on the web link below.

Membership applications

Annual General Meeting

The next ESE AGM will be held on Tuesday 1 May 2007 at the ECE 2007 in Budapest. The draft agenda has been circulated to members but if you would like to receive a copy please contact the ESE Secretariat on info@euro-endo.org.

ECE 2008

The 10th European Congress of Endocrinology will be hosted by the German Endocrine Society and will be held at the ICC in Berlin, 3 - 7 May 2008. The call for abstracts and registration is due to open in March 2007 - keep an eye on the website www.ece2008.com for further details.

www.ece2008.com

Gaining Access to Rare Disease Research Resources

The ESE would like to alert members that a funding workshop is available for Gaining Access to Rare Disease Research Resources. The 2 day European Workshop is to be held on 4-5 May 2007 at the Pasteur Institute, Paris. The deadline for registration is 31 March 2007. Further information on centres of reference for rare diseases and the taskforce newsletter can be found via the links below.

Workshop website

Newsletter

Centres of reference for rare diseases

European regulation on paediatric medicines comes into force (via NELM, 18 January 2007)

A new European regulation on paediatric medicines entered into force on 26 January this year.

EMEA press release

International Convention against Doping in Sport entered into force 1st Feb

On 1 February 2007 the International Convention against Doping in Sport entered into force, the purpose of which to promote the prevention of and the fight against doping in sport, with a view to its elimination. Full details can be found via the link.

Full article

EU Cosmetic testing and safety: SCCP publish guidance

The Scientific Committee on Consumer Products have published notes of guidance for the testing of cosmetic ingredients and their safety evaluation. This was adopted during the 10th plenary meeting of 19th December and can be found via the link below.

SCCP Guidance

WADA February Update of Code Review & World Conference Dates

WADA's February update on the World Anti-Doping Code Review & Consultation is available online, along with details of their latest activities. Follow the link below.

WADA

Rare diseases project profile: Ens@t - The European Network for the Study of Adrenal Tumors

Founded in 2002, ENS@T aims to improve the understanding of the genetics, tumorigenesis and hypersecretion in patients with adrenal tumors and syndromes and to improve the prediction of recurrences and the management of malignant tumors. Because adrenal tumours are rare, they do not benefit from well controlled therapeutic trials with new drugs. To tackle this problem the project aims to bring the issue to a wider European level. Visit the website for further information.

www.ensat.org

GH in patients with tibial fracture

Growth hormone (GH) plays an important role in bone remodelling due to its stimulatory effect on osteoblast cells. In this paper, Raschke et al studied the safety and efficacy of using GH in the healing of tibial fractures. Currently, surgery for these fractures often results in slow healing time and even non-union in some cases. A total of 368 patients (75% male) completed the trial, which tested 15, 30 and 60ug/kg/day GH doses against placebo for both open and closed fractures (29 and 71% respectively). Treatment commenced 3 days post-surgery and continued for 16 weeks or until healed, whichever was sooner. Both radiological and clinical evaluations were performed until a year after surgery. The author's results indicate that GH does not accelerate total healing time when both strata are considered. However, if closed fractures are considered separately, a significant difference was seen between treatment groups, with the most noticeable acceleration of healing shown in the 60ug/kg/day GH treatment group. Furthermore, it seemed to be more effective in women. The trial raised no new safety issues for GH and suggests that it may be useful for patients with closed tibial fractures. Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial Raschke M, Rasmussen MH, Govender S, Segal D, Suntum M and Christiansen JS EJE 156-3 DOI: 10.1530/EJE-06-0598

Clinical Neuroendocrinology Fellow position, Barcelona

A position for a Spanish-speaking MD is available in a University hospital in Barcelona, Spain. Candidates will have to register in the Barcelona College of Physicians and validate their University degree according to the regulations of the Spanish Health Ministry. Subject: clinical research with patients suffering from pituitary diseases (pathophysiology, epidemiology, morbidity-mortality, prognosis, treatment, quality of life, etc.). Salary: approximately 1400 Euros/month. Starting date: Second trimester 2007. Duration: Initially 1 year, extendable if interested. The possibility of a PH.D thesis is feasible. Interested candidates should send their CV with a one page letter in Spanish indicating why they would like this position, by March 15 2007 to Prof. Susan Webb (e-mail: swebb@santpau.es).

COST Open Call for Proposals to support Scientific and Technical Collaboration in Europe

COST (European Co-operation in the field of Scientific & Technical Research) invites researchers throughout Europe to submit proposals for research networks and use this unique opportunity to exchange knowledge and to embark on new European perspectives. COST's main objective is to stimulate new, innovative and interdisciplinary scientific networks in Europe. COST activities (Actions) are carried out by research teams to strengthen the foundations for building scientific excellence in Europe. This continuous call is thematically open. The next collection date for Preliminary Proposals is 30 March 2007.

Link

Studies on the Management of Diabetes and Blood Glucose Abnormalities, European Foundation for the Study of Diabetes

Via www.RDFunding.org. An EFSD/Sanofi-aventis European Programme for the Funding of Studies on the Management of Diabetes and Blood Glucose Abnormalities in Patients with Cardiovascular Disease. Applications from studies measuring parameters of blood glucose control, cardiac function, endothelial function, lipid metabolism or evaluating microvascular complications in patients with a chronic cardiovascular disease, or experiencing an acute cardiovascular event, before and after insulin treatment compared to other treatments, or comparing different insulin treatment regimens, will be specially considered. Full details can be found on the RDFunding website, link below. Closing date: 15 January 2008.

Full details

If you have any feedback on the content of the alert, email: jo.thurston@endocrinology.org

Please feel free to pass this email alert on to anyone you think may be interested.